In another study, vaccination of mice with an irradiated GM-CSF transduced MHC-I-negative tumor vaccine (B78H1-GM-CSF) protected mice against MHC-I-negative tumor challenge, and depletion of either CD4+ T cells or NK cells completely abrogated tumor rejection (42). This evidence concerns the gene CD4 and neoplasm.